The University of Tor Vergata is a public research university located in Rome, Italy. The university combines a liberal arts tradition with emphasis on career orientation in the field of Economics, Engineering, Mathematics and Physics, Natural Sciences, and Medicine.
Department of Biomedicine and Prevention of the The University of Rome Tor Vergata has recently joined the BPDCN International Registry.
About the BPDCN International Registry
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy discovered in 2008. The International Registry is a multicenter, international prospective and retrospective registry with the aim of collecting data of patients with a diagnosis of BPDCN globally. If you think your hospital would benefit from partnership in this registry, please contact Dr.Astghik Voskanyan ([email protected])
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048